Affiliation:
1. Translational Research Division Perth Voices Clinic Murdoch Australia
2. School of Psychology Murdoch University Murdoch Australia
3. School of Psychology Curtin University Curtin Australia
4. Department of Psychology, Faculty of Science The University of Sheffield Sheffield UK
5. Community Mental Health Team Pennine Care National Health Service (NHS) Foundation Trust Manchester UK
Abstract
ABSTRACTIntroductionVisual hallucinations (VH) are more common than previously thought and are linked to higher levels of distress and disability in people with a psychotic illness. Despite this, scant attention has been given to VHs in the clinical literature, and the few therapy case series of cognitive behavioural therapy (CBT) published to date have not demonstrated reliable change. In other areas of clinical research, problematic mental imagery has been found to be more strongly related to negative affect in psychological disorders than negative linguistic thinking, and imagery focused techniques have commonly been found to improve the outcomes in CBT trials. Given VHs have many similarities with visual mental imagery and many of the distressing beliefs associated with VHs targeted in CBT are maintained by accompanying mental imagery (i.e., imaging a hallucinated figure attacking them), it seems plausible that an imagery‐focused approach to treating VHs may be most effective.MethodsThe current study is a multiple baseline case series (N = 11) of a 10‐session imagery‐focused therapy for VH in a transdiagnostic sample.ResultsThe study had good attendance and feedback, no adverse events and only one [seemly unrelated] drop‐out, suggesting good feasibility, safety and acceptability. The majority of clients reported reduction on both full‐scale measures (administered at 3 baselines, midtherapy, posttherapy and 3‐month follow‐up) and weekly measures of VH severity and distress, ranging from medium to large effect sizes.ConclusionsThe case series suggests that an imagery‐focused approach to treating VHs may be beneficial, with a recommendation for more rigorous clinical trials to follow.